Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | CDC25A | P30304 | 6/20 | 0.40 |
| ▸ | CDC25B | P30305 | 6/20 | 0.40 |
| ▸ | CDC25C | P30307 | 5/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 12/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.39 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.39 |
| ▸ | MPEG1 | Q2M385 | 6/20 | 0.36 |
| ▸ | XIAP | P98170 | 2/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15687665 | 1.00 | ACHE (0.44) | ACHEBACE1PTPN1CDC25ACDC25B | |
| SCHEMBL1548523 | 0.93 | ACHE (0.35) | ACHEBACE1PTPN1CDC25ACDC25B | |
| SCHEMBL15692273 | 0.89 | CDC25A (0.36) | ACHEBACE1PTPN1CDC25ACDC25B | |
| SCHEMBL6135976 | 0.85 | ACHE (0.30) | ACHEBACE1PTPN1 | |
| SCHEMBL6939829 | 0.83 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL6943401 | 0.82 | — | — | |
| SCHEMBL4416086 | 0.80 | — | — | |
| SCHEMBL14613199 | 0.79 | — | — | |
| SCHEMBL8921071 | 0.78 | ACHE (0.50) | ACHEBACE1PTPN1CDC25ACDC25B | |
| SCHEMBL6413040 | 0.78 | ACHE (0.50) | ACHEBACE1PTPN1CDC25ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1787988-A2 | Production of furanones | Biosignal Australia Pty Limited (AU) | 2007-05-23 | — | — | EP | disclosed |
| US-20050215772-A1 | Furanone derivatives and methods of making same | BIOSIGNAL LIMITED (AT) | 2005-09-29 | — | — | US | disclosed |
| EP-1539692-A4 | FURANONE DERIVATIVES AND METHODS OF MAKING SAME | BIOSIGNAL LTD (AU) | 2005-08-24 | — | — | EP | disclosed |
| EP-1539692-A1 | FURANONE DERIVATIVES AND METHODS OF MAKING SAME | Biosignal Limited (AU) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004016588-A1 | FURANONE DERIVATIVES AND METHODS OF MAKING SAME | BIOSIGNAL LIMITED (AU) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215772-A1 | Furanone derivatives and methods of making same | PFAS, CFAP20, FDPS | ACHE 1264/4885BACE1 2163/4885PTPN1 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.